The wire › SEC Form 8-K
ADC Therapeutics SA ADCT
Filed with the SEC on Jun 12, 2025. Reported event date Jun 11, 2025.
- Business address
- Epalinges, V8
- State
- Outside the U.S. or not given
- Incorporated in
- Outside the U.S. or not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1771910
- Accession number
- 0000950103-25-007282
Items reported in this filing
- Item 1.01 Entry into a Material Definitive Agreement
- Item 2.05 Costs Associated with Exit or Disposal Activities
The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.
- Item 3.02 Unregistered Sales of Equity Securities
- Item 9.01 Financial Statements and Exhibits
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing